Evidence map›Paper›PMID 37304203›Full record

ArticleJournal of the Endocrine Society2023

Estimated Glucose Disposal Rate Predicts Renal Progression in Type 2 Diabetes Mellitus: A Retrospective Cohort Study.

Juan Peng, Aimei Li, Liangqingqing Yin, Qi Yang, Jinting Pan, Bin Yi

Abstract read
In one paragraph

Article in Journal of the Endocrine Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Juan PengDepartment of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.ORCID https://orcid.org/0000-0001-5154-3011
Aimei LiDepartment of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
Liangqingqing YinDepartment of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
Qi YangDepartment of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
Jinting PanDepartment of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
Bin YiDepartment of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.ORCID https://orcid.org/0000-0002-4972-1226

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Context: Insulin resistance is a feature of type 2 diabetes mellitus (T2DM). The estimated glucose disposal rate (eGDR), a validated marker for insulin resistance, is associated with complications of diabetes, but few studies have explored the relationship between eGDR and renal outcomes in T2DM. Objective: This study investigated the value of eGDR in predicting renal progression in T2DM. Methods: A total of 956 T2DM patients with a baseline estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m Results: Rapid eGFR decline was experienced by 23.95% of patients, 21.97% with eGFR <60 mL/min/1.73 m Conclusion: Lower eGDR is a predictive factor for renal deterioration in T2DM patients.

Indexed as

estimated glomerular filtration rateestimated glucose disposal ratetype 2 diabetes mellitus

Identifiers

PMID37304203
PMCPMC10251298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.